51.53
Boston Scientific Corp stock is traded at $51.53, with a volume of 8.25M.
It is down -0.47% in the last 24 hours and up +17.16% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$51.83
Open:
$51.71
24h Volume:
8.25M
Relative Volume:
0.40
Market Cap:
$74.66B
Revenue:
$20.62B
Net Income/Loss:
$3.56B
P/E Ratio:
21.61
EPS:
2.3847
Net Cash Flow:
$3.48B
1W Performance:
+2.23%
1M Performance:
+17.16%
6M Performance:
-32.38%
1Y Performance:
-50.00%
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
51.52 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
ABT
Abbott Laboratories
|
110.14 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
332.14 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
90.67 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
EW
Edwards Lifesciences Corp
|
90.79 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-26 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - finance.yahoo.com
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Union Bancaire Privee UBP SA Sells 173,105 Shares of Boston Scientific Corporation $BSX - MarketBeat
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance Australia
Here’s What Hurt Boston Scientific Corporation (BSX) in Q2 - Yahoo Finance
Boston Scientific Corporation $BSX Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Security National Bank Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
QRG Capital Management Inc. Buys 198,951 Shares of Boston Scientific Corporation $BSX - MarketBeat
NewEdge Advisors LLC Sells 27,583 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Purchased by Fisher Funds Management LTD - MarketBeat
Brookstone Capital Management Sells 233,448 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boston Scientific Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Boston Scientific's CEO Bought $9M of His Own Stock - Quiver Quantitative
Boston Scientific (BSX) SVP Emily Woodworth adds 2,930 shares in 401(k) rebalance - Stock Titan
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals - ChartMill
Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX - MarketBeat
MiRus founder builds medtech firm worth billions after quest to save others from fate of his mentorAtlanta Business Chronicle - The Business Journals
Boston Scientific Corporation $BSX Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific (BSX) CFO adds 9,908 shares through discretionary 401(k) rebalancing - Stock Titan
Handelsbanken Fonder AB Sells 1,002,628 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp (BSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boston Scientific Corporation (NYSE:BSX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone (NYSE:BSX) - Seeking Alpha
Fidelity Series Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Stock Is Priced As If WATCHMAN Were The Whole Company - Yahoo Finance
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026? - The Motley Fool
Boston Scientific Executives Set for 35-Minute Wells Fargo Q&A - Stock Titan
Boston Scientific Corporation $BSX Shares Bought by Gradient Investments LLC - MarketBeat
Boston Scientific Corp (BSX) Insider David Habiger Buys 2,100 Sh - GuruFocus
Boston Scientific Corporation $BSX Shares Purchased by PensionDanmark Pensionsforsikringsaktieselskab - MarketBeat
Boston Scientific (NYSE:BSX) Director David Habiger Acquires 2,100 Shares - MarketBeat
Boston Scientific (NYSE: BSX) director adds 2,100 shares in open-market buy - Stock Titan
Assenagon Asset Management S.A. Cuts Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Needham cuts Boston Scientific stock price target on WATCHMAN sales - Investing.com
A Look at Boston Scientific Corp (BSX) After 3.3% Gain -- GF Val - GuruFocus
FMR LLC (NYSE: BSX) discloses 46.4M-share Boston Scientific stake in 13G/A - Stock Titan
Michael Mahoney Acquires 186,240 Shares of Boston Scientific (NYSE:BSX) Stock - MarketBeat
Boston Scientific (NYSE: BSX) CEO adds 186,240 shares in open-market buy - Stock Titan
Boston Scientific (NYSE: BSX) director adds 1,182 shares in August stock purchases - stocktitan.net
Boston Scientific Corporation (BSX) options chain - Yahoo Finance Australia
Should Investors Buy Boston Scientific Stock Despite Near-Term Risks? - Yahoo Finance
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):